Related Experiment Video
Updated: May 13, 2026
08:44
Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
Childhood lung function and the association with β2-adrenergic receptor haplotypes
Tale M Torjussen1, Monica C Munthe-Kaas, Petter Mowinckel
1Department of Paediatrics, Women and Children's Division, Oslo University Hospital, Oslo, Norway. t.m.torjussen@medisin.uio.no
Acta Paediatrica (Oslo, Norway : 1992)
|March 8, 2013
Summary
A specific ADRB2 gene variation (haplotype I, CGGC) may protect 10-year-old children from reduced lung function (FEV1). This genetic influence on lung development appears independent of environmental factors like smoke exposure, pets, or gender.
Area of Science:
- Genetics
- Pediatric Pulmonology
- Environmental Health
Background:
- Adrenergic receptor B2 (ADRB2) gene polymorphisms are investigated for their role in respiratory health.
- Lung function development in children can be influenced by genetic and environmental factors.
- Understanding these influences is crucial for addressing childhood respiratory conditions.
Purpose of the Study:
- To investigate the association between ADRB2 gene polymorphisms and lung function in children.
- To explore potential modifications of this association by gender, pet ownership, and tobacco smoke exposure.
- To determine the impact of ADRB2 genotypes on lung function from birth to age 10.
Main Methods:
- Genotyping of four ADRB2 single nucleotide polymorphisms (SNPs) in 953 children from a prospective birth cohort.
- Analysis of lung function parameters (tidal breathing at birth, forced expiration at 10 years).
- Stratification of analyses by environmental exposures: gender, pet keeping, and tobacco smoke.
Main Results:
- A common ADRB2 haplotype (CGGC, haplotype I) was associated with a reduced risk of decreased lung function in 10-year-old children (OR 0.45).
- No significant associations were found between ADRB2 haplotypes and lung function at birth.
- Environmental factors (tobacco smoke, gender, pet keeping) did not significantly modify the effect of ADRB2 haplotypes on lung function.
Conclusions:
- The ADRB2 haplotype I (CGGC) may offer a protective effect against reduced FEV1 (forced expiratory volume in 1 second) in 10-year-old children.
- ADRB2 genotypes do not appear to influence neonatal lung function.
- The ADRB2 gene plays a role in childhood lung function development, independent of common environmental exposures.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...